Aripiprazole Tablet
Product Images NDC 70518-2974

12 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Aripiprazole (NDC 70518-2974). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Aripiprazole Structure (Aripiprazole Fig8)

Aripiprazole Structure (Aripiprazole Fig8)
Chemical structure diagram of the active ingredient Aripiprazole, as shown in the image. The structure includes characteristic aromatic rings, a piperazine ring, and chlorophenyl groups consistent with Aripiprazole's molecular composition.*
FDA Label Image

Effects Of Other Drugs On Aripiprazole (Aripiprazole Fig9)

Effects Of Other Drugs On Aripiprazole (Aripiprazole Fig9)
A pharmacokinetic (PK) chart illustrating the fold change and 90% confidence intervals (CI) of aripiprazole exposure, measured by AUC and Cmax, when co-administered with various inhibitors, inducers, and other drugs including ketoconazole, quinidine, carbamazepine, famotidine, valproate, lithium, and lorazepam. The x-axis shows change relative to reference without interacting drug.*
FDA Label Image

Effects Of Other Drugs On Dehydro-aripiprazole (Aripiprazole Fig10)

Effects Of Other Drugs On Dehydro-aripiprazole (Aripiprazole Fig10)
A pharmacokinetic chart titled 'Dehydro-Aripiprazole Fold Change and 90% CI' showing the effects of various interacting drugs, including CYP3A4 and CYP2D6 inhibitors and inducers, gastric acid blockers, and others, on the change in AUC and Cmax of Dehydro-Aripiprazole relative to a reference without interacting drugs.*
FDA Label Image

Effects Of Aripiprazole On Pharmacokinetics Of Other Drugs (Aripiprazole Fig11)

Effects Of Aripiprazole On Pharmacokinetics Of Other Drugs (Aripiprazole Fig11)
A forest plot showing fold changes and 90% confidence intervals in pharmacokinetic parameters (AUC and Cmax) and INR for various drugs when taken with or without an interacting drug. The plot includes drugs like dextromethorphan, warfarin, omeprazole, valproate, lithium, venlafaxine, escitalopram, and others, with their relative changes compared to a reference.*
FDA Label Image

Effects Of Intrinsic Factors On Aripiprazole (Aripiprazole Fig12)

Effects Of Intrinsic Factors On Aripiprazole (Aripiprazole Fig12)
A pharmacokinetic chart depicting fold change and 90% confidence intervals of Aripiprazole plasma exposure variables (AUC and Cmax) across various factors. Factors include CYP2D6 metabolizer status, gender, age groups, hepatic impairment levels, and severe renal impairment. The chart shows the relative change compared to reference conditions for each factor.*
FDA Label Image

Effects Of Intrinsic Factors On Dehydro-aripiprazole (Aripiprazole Fig13)

Effects Of Intrinsic Factors On Dehydro-aripiprazole (Aripiprazole Fig13)
A forest plot chart titled 'Dehydro-Aripiprazole Fold Change and 90% CI' showing the effects of various factors (CYP2D6 metabolism status, gender, age, hepatic impairment, and severe renal impairment) on AUC and Cmax relative to reference values. The x-axis represents change relative to reference, ranging from 0.5 to 3.0, with data points and confidence intervals displayed for each factor comparison.*
FDA Label Image

Aripiprazole-graph-a (Aripiprazole Graph A)

Aripiprazole-graph-a (Aripiprazole Graph A)
A survival curve chart showing the proportion of subjects with relapse over 182 days from randomization, comparing Aripiprazole and placebo groups. The graph includes the number of subjects at risk at various time points for both groups, indicating lower relapse rates in the Aripiprazole group compared to placebo.*
FDA Label Image

Aripiprazole-fig-16-a (Aripiprazole Fig 16 A)

Aripiprazole-fig-16-a (Aripiprazole Fig 16 A)
A Kaplan-Meier curve comparing the proportion of subjects with relapse over 182 days from randomization between Aripiprazole and placebo groups. The solid line represents Aripiprazole, showing a lower relapse proportion over time, while the dashed line represents placebo with a higher relapse proportion. A table below displays the number of subjects at risk in each group across time points.*
FDA Label Image

Aripiprazole-fig-17-a (Aripiprazole Fig 17 A)

Aripiprazole-fig-17-a (Aripiprazole Fig 17 A)
A line chart comparing the proportion of subjects with relapse over 364 days from randomization between Aripiprazole and placebo groups. The x-axis shows days from randomization, and the y-axis shows the proportion with relapse. The chart includes subject counts at risk for each group below the x-axis.*
FDA Label Image

Aripiprazole-fig-18 (Aripiprazole Fig 18)

Aripiprazole-fig-18 (Aripiprazole Fig 18)
A line graph showing the change in YGTSS Total TIC Score from baseline over 8 weeks of treatment. The graph compares three groups: Aripiprazole Low, Aripiprazole High, and Placebo, with the least-squares mean changes plotted against weeks of treatment.*
FDA Label Image

Mm1 (Aripiprazole 30mg 70518 2974 00)

Mm1 (Aripiprazole 30mg 70518 2974 00)
Aripiprazole 30 mg tablet label showing a package quantity of 30 tablets. The label includes the NDC number 70518-2974-00 and states the product is repackaged by RemedyRepack Inc., Indiana, PA. Storage instructions recommend keeping the medication out of children's reach and storing between 20-25°C with permitted excursions. The label notes the dosage form as a round pink tablet.*
FDA Label Image

Mm2 (Aripiprazole 30mg 70518 2974 01)

Mm2 (Aripiprazole 30mg 70518 2974 01)
Packaging label for Aripiprazole 30 mg oral tablets, quantity of 30, labeled for prescription use only (RX ONLY). The label shows the NDC number 70518-2974-01 and indicates repackaging by RemedyRepack Inc. The manufacturer is Ascend Labs, LLC, Montvale, NJ. Storage instructions and a QR code are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.